Top Markets
Coin of the day
Ibere Pharmaceuticals Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER
Rank in Stocks #19087
Ibere Pharmaceuticals currently lacks significant operational activities, with... Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Share Price
$10.18
Last synced: 2023-03-01
Market Cap
$175.61M
Change (1 day)
-0.29%
Change (1 year)
0.00%
Country
US
Trade Ibere Pharmaceuticals (IBER)
Revenue for Ibere Pharmaceuticals (IBER)
Revenue in Aug 2026 TTM: 0
According to Ibere Pharmaceuticals latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ibere Pharmaceuticals from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors